AMANDA TSANG: Open Payments
NPI 1215493812 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 26 payments from 6 companies in 2025. Trend: 2023 $666 · 2024 $570 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $378 |
| Novo Nordisk Inc | 8 | $186 |
| Xeris Pharmaceuticals, Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $48 |
| Antares Pharma, Inc. | 1 | $25 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $25 |
Products named: MOUNJARO, Wegovy, ZEPBOUND, RECORLEV, CREON, JARDIANCE, XYOSTED, ISTURISA.
Industry payments across NY — which companies pay providers there.
